Cargando…

Newly Developed Recombinant Antithrombin Protects the Endothelial Glycocalyx in an Endotoxin-Induced Rat Model of Sepsis

(1) Background: The endothelial glycocalyx is a primary target during the early phase of sepsis. We previously reported a newly developed recombinant non-fucosylated antithrombin has protective effects in vitro. We further evaluated the effects of this recombinant antithrombin on the glycocalyx dama...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iba, Toshiaki, Levy, Jerrold H., Aihara, Koichiro, Kadota, Katsuhiko, Tanaka, Hiroshi, Sato, Koichi, Nagaoka, Isao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795760/ https://www.ncbi.nlm.nih.gov/pubmed/33375342 http://dx.doi.org/10.3390/ijms22010176

Ejemplares similares

Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin
por: Iba, Toshiaki, et al.
Publicado: (2018)

Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation
por: Iba, Toshiaki, et al.
Publicado: (2018)

The Comparison of the Protective Effects of α- and β-Antithrombin against Vascular Endothelial Cell Damage Induced by Histone in Vitro
por: Iba, Toshiaki, et al.
Publicado: (2017)

Recent advances in the research and management of sepsis-associated DIC
por: Iba, Toshiaki, et al.
Publicado: (2021)

The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2023)

Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunction
por: Iba, Toshiaki, et al.
Publicado: (2015)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2017)

Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model
por: Iba, Toshiaki, et al.
Publicado: (2009)

Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2014)

Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2019)

Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
por: Wada, Hideo, et al.
Publicado: (2023)

Intracellular communication and immunothrombosis in sepsis
por: Iba, Toshiaki, et al.
Publicado: (2022)

Inhibition of endotoxin-induced leukocyte/endothelial cell interaction by antithrombin III
por: Hoffmann, JN, et al.
Publicado: (1999)

The Endothelial Glycocalyx and Neonatal Sepsis
por: Fatmi, Ahlam, et al.
Publicado: (2022)

Is the neutrophil a ‘prima donna’ in the procoagulant process during sepsis?
por: Iba, Toshiaki, et al.
Publicado: (2014)

Antithrombin in sepsis revisited
por: Levi, Marcel
Publicado: (2005)

Nevertheless, the importance of coagulation abnormalities should be emphasized in international sepsis guidelines
por: Iba, Toshiaki, et al.
Publicado: (2022)

Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
por: Iba, Toshiaki, et al.
Publicado: (2019)

The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2023)

Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Akahoshi, Tomohiko, et al.
Publicado: (2022)

Effect of Hemoperfusion Using Polymyxin B-immobilized Fibers on Acute Lung Injury in a Rat Sepsis Model
por: Iba, Toshiaki, et al.
Publicado: (2014)

Nanomechanics of the Endothelial Glycocalyx in Experimental Sepsis
por: Wiesinger, Anne, et al.
Publicado: (2013)

Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki
Publicado: (2015)

New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey
por: Iba, Toshiaki, et al.
Publicado: (2017)

Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity
por: Iba, Toshiaki, et al.
Publicado: (2016)

Low Endotoxin Recovery—Masking of Naturally Occurring Endotoxin
por: Reich, Johannes, et al.
Publicado: (2019)

Newly developed endotoxin measurement method (endotoxin activity assay) may reflect the severity of sepsis
por: Murayama, H, et al.
Publicado: (2009)

Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure
por: Kuroda, Hiromitsu, et al.
Publicado: (2020)

The endothelial glycocalyx degenerates with increasing sepsis severity
por: Köhler, M, et al.
Publicado: (2011)

Lest we forget the endothelial glycocalyx in sepsis
por: Burke-Gaffney, Anne, et al.
Publicado: (2012)

A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis
por: Gando, Satoshi, et al.
Publicado: (2013)

Antimicrobial peptide LL-37 ameliorates a murine sepsis model via the induction of microvesicle release from neutrophils
por: Kumagai, Yumi, et al.
Publicado: (2020)

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey
por: Iba, Toshiaki, et al.
Publicado: (2014)

Antithrombin and free tri-iodothyronine in sepsis
por: Mateu, P, et al.
Publicado: (2004)

Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
por: Chlebowski, Meghan M., et al.
Publicado: (2020)

The Endothelial Glycocalyx: New Diagnostic and Therapeutic Approaches in Sepsis
por: Martin, Lukas, et al.
Publicado: (2016)

Endothelial glycocalyx degradation during sepsis: Causes and consequences
por: Sullivan, Ryan C., et al.
Publicado: (2021)

Protection and rebuilding of the endothelial glycocalyx in sepsis – Science or fiction?
por: Drost, Carolin Christina, et al.
Publicado: (2021)

Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis
por: Wada, Takeshi, et al.
Publicado: (2022)

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia
por: Iba, Toshiaki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_126j4pbnit2it7d23tq78o5o3k